SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2026-05-20 13:55
Tx date 2026-05-19 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Johnson, Neil Allan
4 - Director of Issuer
Direct Ownership
Deferred Share Units
46 - Compensation for services 		$2,500
+16,667 vol
$0.15 each 		45,233
Filed 2026-05-20 11:05
Tx date 2026-05-19 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Smallbone, Sidney Randall
4 - Director of Issuer
Direct Ownership
Deferred Share Units
46 - Compensation for services 		$2,500
+16,667 vol
$0.15 each 		124,670
Filed 2026-05-19 23:34
Tx date 2026-05-19 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Pedram, Babak
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
+16,667 vol 		108,783
Filed 2026-05-19 20:19
Tx date 2024-07-23 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Malaspina Consultants Inc.
5 - Senior Officer of Issuer
Holder: Harry Nijjar (Indirect Ownership)
Options
50 - Grant of options
+250,000 vol 		425,000
Filed 2026-05-19 20:17
Tx date 2022-09-26 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Malaspina Consultants Inc.
5 - Senior Officer of Issuer
Holder: Harry Nijjar (Indirect Ownership)
Options
50 - Grant of options
+175,000 vol 		175,000
Filed 2026-05-19 20:12
Tx date 2022-02-01 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Malaspina Consultants Inc.
5 - Senior Officer of Issuer
Holder: Harry Nijjar (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2026-04-24 08:47
Tx date 2026-02-24 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership
+4,166,667 vol 		7,046,358
Filed 2026-04-24 08:46
Tx date 2026-02-24 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
Common Shares
90 - Change in the nature of ownership
-4,166,667 vol 		5,259,000
Filed 2026-04-14 11:36
Tx date 2026-02-24 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift
+4,166,667 vol
Filed 2026-04-14 11:35
Tx date 2026-02-24 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift
-4,166,667 vol
Filed 2026-04-14 11:36
Tx date 2026-02-24 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift
+4,166,667 vol 		7,046,358
Filed 2026-04-14 11:35
Tx date 2026-02-24 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift
-4,166,667 vol 		5,259,000
Filed 2026-04-14 11:30
Tx date 2026-02-24 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
Common Shares
36 - Conversion or exchange 		$500,000
+4,166,667 vol
$0.12 each 		9,425,667
Filed 2026-02-27 18:10
Tx date 2026-02-24 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange 		$500,000
+4,166,667 vol
$0.12 each
Filed 2026-04-13 12:11
Tx date 2026-02-17 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Johnson, Neil Allan
4 - Director of Issuer
Direct Ownership
Deferred Share Units
46 - Compensation for services 		$2,500
+16,667 vol
$0.15 each 		28,566
Filed 2026-02-27 18:15
Tx date 2026-02-24 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$119,999
+857,142 vol
$0.14 each 		7,046,358
Filed 2026-02-27 18:10
Tx date 2026-02-24 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange 		$500,000
+4,166,667 vol
$0.12 each 		6,189,216
Filed 2026-02-27 18:07
Tx date 2026-02-24 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
Convertible Debentures Convertible Debenture .12 8% due February 24, 2026
36 - Conversion or exchange 		$
-$500,000 vol
$0.12 each 		$0
Filed 2026-02-19 14:26
Tx date 2026-02-17 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Pedram, Babak
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
+16,667 vol 		92,116
Filed 2026-02-18 20:52
Tx date 2026-02-17 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Smallbone, Sidney Randall
4 - Director of Issuer
Direct Ownership
Deferred Share Units
46 - Compensation for services 		$2,500
+16,667 vol
$0.15 each 		108,003